Professor Yangfeng WU - 武阳丰教授
Senior Director Professorial Fellow Principal Investigator, China International Center for Chronic Disease Prevention
Yangfeng is the Professorial Fellow of the Peking University Clinical Research Institute and Professor of Epidemiology in the Department of Epidemiology and Biostatistics at the Peking University School of Public Health. After receiving his undergraduate and graduate training in medicine, public health and epidemiology, Dr Wu started his career as a Research Fellow in the US-PRC Collaborative Study of Cardiovascular and Cardiopulmonary Epidemiology, where he was sent to the US later on through the NIH Scholar Exchange Program for training in epidemiological research.
His research focuses on prevention and control of cardiovascular disease and he has published over 150 peer-reviewed papers in both Chinese and international journals. As a cardiovascular expert, Professor Wu has made valuable contributions to reduce the impact of cardiovascular disease in China.
In 2009, he founded the China International Center for Chronic Disease Prevention in Beijing, a network of 12 Chinese and international research institutions, with the funding awarded by the National Heart, Lung and Blood Institute and the UnitedHealth Group. Through the platform, a large project on low-cost, simple interventions for blood pressure control and stroke prevention involving 120 villages from 10 counties in 5 provinces of China is currently running.
Besides his own research, he made great efforts to develop research platforms for high quality clinical research in China. He is the founding Director of The George Institute for Global Health, China, which is hosting the China International Center for Chronic Disease Prevention. He is also one of the founders of Peking University Clinical Research Institute, the first of its kind in China to provide professional technical support to clinical experts in designing, implementing and analyzing clinical studies.
He is also one of the founders of the Chinese Course on Innovative Drug Development and Regulatory Sciences, an international joint program hosted by Peking University Clinical Research Institute, in collaboration with University of Basal and the University of California at San Francisco. With his advices and suggestions, Peking University Clinical Research Program was launched in 2010, as an innovative model, to support financially, technically and also ethically the innovative ideas in clinical research.
As a Member of the Board, he actively participated in the establishment of the Peking University Health Science Center – University of Michigan Health System Joint Institute of Clinical and Translational Research, another new model of collaboration to promote high quality of clinical research in China. Under his leadership, a new graduate course “Expert Seminar Series on Sciences in Clinical Research” has been launched at Peking University Graduate School in September, 2011 to provide the students the most practice-relevant and advanced knowledge in clinical research. After three years of hard efforts, a system for high quality clinical research including resources for funding, technical supporting, scientific and ethical quality management, training, and administration has been established and started functioning.